581 related articles for article (PubMed ID: 32459615)
1. Emergence of azole resistant-
Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
[No Abstract] [Full Text] [Related]
2. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
[TBL] [Abstract][Full Text] [Related]
3. The emergence of azole resistance in Aspergillus fumigatus complex in New Zealand.
McKinney WP; Vesty A; Sood J; Bhally H; Morris AJ
N Z Med J; 2021 Jun; 134(1536):41-51. PubMed ID: 34140712
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis.
Seyedmousavi S; Melchers WJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2013 Apr; 57(4):1866-71. PubMed ID: 23380732
[TBL] [Abstract][Full Text] [Related]
5. Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report.
Ito Y; Takazono T; Koga S; Nakano Y; Ashizawa N; Hirayama T; Tashiro M; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Izumikawa K; Mukae H
BMC Infect Dis; 2021 Jun; 21(1):573. PubMed ID: 34126952
[TBL] [Abstract][Full Text] [Related]
6. Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?
Hamprecht A; Morio F; Bader O; Le Pape P; Steinmann J; Dannaoui E
Mycopathologia; 2018 Feb; 183(1):151-160. PubMed ID: 28653258
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan.
Wang HC; Huang JC; Lin YH; Chen YH; Hsieh MI; Choi PC; Lo HJ; Liu WL; Hsu CS; Shih HI; Wu CJ; Chen YC
Environ Microbiol; 2018 Jan; 20(1):270-280. PubMed ID: 29124846
[TBL] [Abstract][Full Text] [Related]
8. Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
Mellado E; De La Camara R; Buendía B; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2013 Jan; 30(1):64-8. PubMed ID: 22986228
[TBL] [Abstract][Full Text] [Related]
9. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Chowdhary A; Sharma C; Hagen F; Meis JF
Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
[TBL] [Abstract][Full Text] [Related]
10. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
[TBL] [Abstract][Full Text] [Related]
11. Azole resistance mechanisms and population structure of the human pathogen
Wang C; Miller N; Vines D; Severns PM; Momany M; Brewer MT
Appl Environ Microbiol; 2024 May; 90(5):e0205623. PubMed ID: 38651929
[No Abstract] [Full Text] [Related]
12. Azole Resistance in Veterinary Clinical Aspergillus fumigatus Isolates in the Netherlands.
van Dijk MAM; Buil JB; Tehupeiory-Kooreman M; Broekhuizen MJ; Broens EM; Wagenaar JA; Verweij PE
Mycopathologia; 2024 Jun; 189(4):50. PubMed ID: 38864903
[TBL] [Abstract][Full Text] [Related]
13. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
[TBL] [Abstract][Full Text] [Related]
14. Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46/Y121F/T289A isolated in Japan.
Hagiwara D; Takahashi H; Fujimoto M; Sugahara M; Misawa Y; Gonoi T; Itoyama S; Watanabe A; Kamei K
J Infect Chemother; 2016 Aug; 22(8):577-9. PubMed ID: 26898666
[TBL] [Abstract][Full Text] [Related]
15. Azole-resistant Aspergillus fumigatus: A global phenomenon originating in the environment?
Jeanvoine A; Rocchi S; Bellanger AP; Reboux G; Millon L
Med Mal Infect; 2020 Aug; 50(5):389-395. PubMed ID: 31472992
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
Amorim A; Guedes-Vaz L; Araujo R
Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
[TBL] [Abstract][Full Text] [Related]
17. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
Snelders E; Melchers WJ; Verweij PE
Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
[TBL] [Abstract][Full Text] [Related]
18. [Azole resistance with environmental origin: What alternatives for the future?].
Rocchi S; Reboux G; Millon L
J Mycol Med; 2015 Dec; 25(4):249-56. PubMed ID: 26631951
[TBL] [Abstract][Full Text] [Related]
19. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
20. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
Steinmann J; Hamprecht A; Vehreschild MJ; Cornely OA; Buchheidt D; Spiess B; Koldehoff M; Buer J; Meis JF; Rath PM
J Antimicrob Chemother; 2015 May; 70(5):1522-6. PubMed ID: 25630644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
